Bristol Myers Squibb (BMY) — insider trading
Health Care · NYSE
Bristol Myers Squibb (BMY) has 40 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 40 (latest 2026-10-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Gallman Cari | Officer (EVP, General Counsel) | Option exercise / conversion (derivative) | 4,559 | — | $0 | Form 4 |
| 2026-10-02 | Gallman Cari | Officer (EVP, General Counsel) | Shares withheld for taxes / exercise cost | 2,332 | $61.15 | $142.6K | Form 4 |
| 2026-10-02 | Gallman Cari | Officer (EVP, General Counsel) | Option exercise / conversion | 4,559 | — | $0 | Form 4 |
| 2026-09-30 | Samuels Theodore R. II | Director | Grant / award / vesting (derivative) | 821 | $62.40 | $51.2K | Form 4 |
| 2026-09-30 | McMullen Michael R. | Director | Grant / award / vesting (derivative) | 561 | $62.40 | $35.0K | Form 4 |
| 2026-09-30 | Rice Derica W | Director | Grant / award / vesting (derivative) | 621 | $62.40 | $38.8K | Form 4 |
| 2026-09-30 | YALE PHYLLIS R | Director | Grant / award / vesting (derivative) | 561 | $62.40 | $35.0K | Form 4 |
| 2026-09-30 | Arduini Peter J | Director | Grant / award / vesting (derivative) | 561 | $62.40 | $35.0K | Form 4 |
| 2026-09-09 | Massacesi Cristian | Officer (EVP,Chief Med Offr,Head of Dev) | Open-market sale | 6,249 | $64.57 | $403.5K | Form 4 |
| 2026-09-01 | Short Bartie Wendy | Officer (EVP, Corporate Affairs) | Option exercise / conversion (derivative) | 1,236 | — | $0 | Form 4 |
| 2026-09-01 | Short Bartie Wendy | Officer (EVP, Corporate Affairs) | Shares withheld for taxes / exercise cost | 633 | $66.92 | $42.4K | Form 4 |
| 2026-09-01 | Short Bartie Wendy | Officer (EVP, Corporate Affairs) | Option exercise / conversion | 1,236 | $66.92 | $82.7K | Form 4 |
| 2026-08-25 | Holzer Phil M | Officer (SVP and Controller) | Open-market sale | 500 | $67.50 | $33.8K | Form 4 |
| 2026-08-01 | Gallman Cari | Officer (EVP, General Counsel) | Option exercise / conversion (derivative) | 1,061 | — | $0 | Form 4 |
| 2026-08-01 | Gallman Cari | Officer (EVP, General Counsel) | Shares withheld for taxes / exercise cost | 543 | $65.31 | $35.5K | Form 4 |
| 2026-08-01 | Gallman Cari | Officer (EVP, General Counsel) | Option exercise / conversion | 1,061 | — | $0 | Form 4 |
| 2026-08-01 | Massacesi Cristian | Officer (EVP,Chief Med Offr,Head of Dev) | Option exercise / conversion (derivative) | 51,172 | — | $0 | Form 4 |
| 2026-08-01 | Massacesi Cristian | Officer (EVP,Chief Med Offr,Head of Dev) | Shares withheld for taxes / exercise cost | 26,175 | $65.31 | $1.71M | Form 4 |
| 2026-08-01 | Massacesi Cristian | Officer (EVP,Chief Med Offr,Head of Dev) | Option exercise / conversion | 51,172 | — | $0 | Form 4 |
| 2026-06-30 | Arduini Peter J | Director | Grant / award / vesting (derivative) | 607 | $57.62 | $35.0K | Form 4 |
| 2026-06-30 | McMullen Michael R. | Director | Grant / award / vesting (derivative) | 607 | $57.62 | $35.0K | Form 4 |
| 2026-06-30 | Rice Derica W | Director | Grant / award / vesting (derivative) | 673 | $57.62 | $38.8K | Form 4 |
| 2026-06-30 | Samuels Theodore R. II | Director | Grant / award / vesting (derivative) | 889 | $57.62 | $51.2K | Form 4 |
| 2026-06-30 | YALE PHYLLIS R | Director | Grant / award / vesting (derivative) | 607 | $57.62 | $35.0K | Form 4 |
| 2026-06-15 | Haller Julia A | Director | Option exercise / conversion (derivative) | 20,460 | — | $0 | Form 4 |
| 2026-06-15 | Haller Julia A | Director | Option exercise / conversion | 20,460 | $53.76 | $1.10M | Form 4 |
| 2026-06-03 | Short Bartie Wendy | Officer (EVP, Corporate Affairs) | Option exercise / conversion (derivative) | 8,040 | — | $0 | Form 4 |
| 2026-06-03 | Short Bartie Wendy | Officer (EVP, Corporate Affairs) | Shares withheld for taxes / exercise cost | 3,876 | $54.72 | $212.1K | Form 4 |
| 2026-06-03 | Short Bartie Wendy | Officer (EVP, Corporate Affairs) | Option exercise / conversion | 8,040 | — | $0 | Form 4 |
| 2026-05-01 | Lenkowsky Adam | Officer (EVP, Chief Commercial Officer) | Option exercise / conversion (derivative) | 1,373 | — | $0 | Form 4 |
| 2026-05-01 | Lenkowsky Adam | Officer (EVP, Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 599 | $58.22 | $34.9K | Form 4 |
| 2026-05-01 | Lenkowsky Adam | Officer (EVP, Chief Commercial Officer) | Other acquisition or disposition | 203 | — | $0 | Form 4 |
| 2026-05-01 | Lenkowsky Adam | Officer (EVP, Chief Commercial Officer) | Option exercise / conversion | 1,373 | — | $0 | Form 4 |
| 2026-04-01 | Elkins David V | Officer (EVP, Chief Financial Officer) | Open-market sale | 4,481 | $62.05 | $278.0K | Form 4 |
| 2026-04-01 | Elkins David V | Officer (EVP, Chief Financial Officer) | Open-market sale | 25,519 | $61.60 | $1.57M | Form 4 |
| 2026-04-01 | Shanahan Karin | Officer (EVP, Chief Supply Chain & Ops) | Option exercise / conversion (derivative) | 3,307 | — | $0 | Form 4 |
| 2026-04-01 | Shanahan Karin | Officer (EVP, Chief Supply Chain & Ops) | Shares withheld for taxes / exercise cost | 1,692 | $61.73 | $104.4K | Form 4 |
| 2026-04-01 | Shanahan Karin | Officer (EVP, Chief Supply Chain & Ops) | Option exercise / conversion | 3,307 | — | $0 | Form 4 |
| 2026-03-31 | Samuels Theodore R. II | Director | Grant / award / vesting (derivative) | 845 | $60.65 | $51.2K | Form 4 |
| 2026-03-31 | YALE PHYLLIS R | Director | Grant / award / vesting (derivative) | 577 | $60.65 | $35.0K | Form 4 |
Ask the chat about BMY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Bristol Myers Squibb (BMY).
Last updated 2026-10-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.